We are funded by the National Institute for Health Research to support experimental medicine, early phase studies (phase IIa and earlier) and experimental medicine studies that are ‘nested’ within later phase studies that require specialised facilities, support or equipment.
Our superbly equipped generic and specialist facilities are staffed by a dedicated and highly trained team with all the clinical skills needed to support your research project. This includes chemotherapy, immunotherapy, cell therapy, monoclonal antibody and vaccine drug administration, endoscopy procedures, metabolic and physiological measurement studies and intensive sampling studies such as euglycaemic clamps and artificial pancreas. We have created the research environment for innovation and excellence in translating experimental medicine into patient benefits.
NIHR acknowledgement in Publications
The operating costs of our facilities are funded by the National Institute for Health Research (NIHR). The NIHR requires you to acknowledge the NIHR in all publications/ abstracts/ posters/ press releases/ media coverage arising from work under taken in our facilities, as follows:
‘This research was funded by XXX [name of funder(s)] and supported by the NIHR Cambridge Clinical Research Facility.’
Or the shorter format:
‘This research was supported by the NIHR Cambridge CRF.’
For further guidance, please speak to one of our Matrons.